SCIENTIFIC STUDIES MANUFACTURED BY MONSANTO ABOUT ROUNDUP SHOULD BE THROWN OUT
To Rick P. Keigwin, Jr., Acting Director of the EPA's Office of Pesticide Programs:
The review of the carcinogenic potential of glyphosate is a serious matter that could have massive implications. But newly released emails show that the corporation Monsanto may have "ghost-written" scientific studies affirming the safety of glyphosate. Monsanto has a financial stake in the registration of glyphosate, as its product Roundup grosses as much as $1 billion per year for Monsanto.
To ensure your review of glyphosate is not affected by corporate influence, but based on sound and independent science, please do not consider the following studies, which were likely written in part by Monsanto: 1) Greim, et al. (2015), Evaluation of carcinogenic potential of the herbicide glyphosate, drawing on tumor incidence data from fourteen chronic/carcinogenicity rodent studies; 2) Kier & Kirkland (2013), Review of genotoxicity studies of glyphosate and glyphosate-based formulations; and, 3) Williams (2000), Safety evaluation and risk assessment of the herbicide Roundup and its active ingredient, glyphosate, for humans.